Gut Pathogens | |
Serologic host response to Helicobacter pylori and Campylobacter jejuni in socially housed Rhesus macaques (Macaca mulatta) | |
Martin J Blaser7  Maria Gloria Dominguez-Bello5  Janis A Gonzalez-Martinez1  Andre Dubois6  Huilin Li3  Rafael Tosado-Acevedo8  Juan L Rivera-Correa5  Guillermo I Perez-Perez4  Sabine Kienesberger2  | |
[1] Caribbean Primate Research Center, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA;Department of Medicine, NYU Langone Medical Center, New York, NY, USA;Department of Population Health, NYUSOM, New York, NY, USA;Department of Microbiology, NYU Langone Medical Center, New York, NY, USA;Department of Biology, University of Puerto Rico, San Juan, PR, USA;Digestive Diseases Division, Department of Medicine, Uniformed Services of the Health Sciences, Bethesda, MD, USA;VA Medical Center, New York, NY, USA;Interamerican University of Puerto Rico, Metropolitan Campus, San Juan, PR, USA | |
关键词: CagA; Sero-prevalence; Antibodies; Rhesus macaques; Campylobacter jejuni; Helicobacter pylori; | |
Others : 821946 DOI : 10.1186/1757-4749-4-9 |
|
received in 2012-07-09, accepted in 2012-08-17, 发布年份 2012 | |
【 摘 要 】
Background
Helicobacter pylori are successful colonizers of the human gastric mucosa. Colonization increases the risk of peptic ulcer disease and adenocarcinoma. However, potential benefits of H. pylori colonization include protection against early-onset asthma and against gastrointestinal infections. Campylobacter jejuni are a leading cause of bacterial diarrhea and complications include Guillain-Barré syndrome. Here, we describe the development of reliable serological assays to detect antibodies against those two bacteria in Rhesus macaques and investigated their distribution within a social group of monkeys.
Methods
Two cohorts of monkeys were analyzed. The first cohort consisted of 30 monkeys and was used to establish an enzyme-linked immunosorbent assay (ELISA) for H. pylori antibodies detection. To evaluate colonization of those macaques, stomach biopsies were collected and analyzed for the presence of H. pylori by histology and culture. C. jejuni ELISAs were established using human serum with known C. jejuni antibody status. Next, plasma samples of the 89 macaques (Cohort 2) were assayed for antibodies and then statistically analyzed.
Results
An H. pylori IgG ELISA, which was 100% specific and 93% sensitive, was established. In contrast, the IgA ELISA was only 82% specific and 61% sensitive. The CagA IgG assay was 100% sensitive and 61% of the macaques were positive. In cohort 2, 62% macaques were H. pylori sero-positive and 52% were CagA positive. The prevalence of H. pylori IgG and CagA IgG increased with monkey age as described for humans. Of the 89 macaques 52% showed IgG against C. jejuni but in contrast to H. pylori, the sero-prevalence was not associated with increasing age. However, there was a drop in the IgG (but not in IgA) mean values between infant and juvenile macaques, similar to trends described in humans.
Conclusions
Rhesus macaques have widespread exposure to H. pylori and C. jejuni, reflecting their social conditions and implying that Rhesus macaques might provide a model to study effects of these two important human mucosal bacteria on a population.
【 授权许可】
2012 Kienesberger et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140712090950633.pdf | 591KB | download | |
Figure 3. | 47KB | Image | download |
Figure 2. | 96KB | Image | download |
Figure 1. | 67KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
【 参考文献 】
- [1]Perez-Perez GI, Salomaa A, Kosunen TU, Daverman B, Rautelin H, Aromaa A, Knekt P, Blaser MJ: Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(−) strains. Gut 2002, 50:295-298.
- [2]Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA: The cohort effect and Helicobacter pylori. J Infect Dis 1993, 168:219-221.
- [3]Mishra S, Singh V, Rao GR, Dixit VK, Gulati AK, Nath G: Prevalence of Helicobacter pylorin asymptomatic subjects–a nested PCR based study. Infect Genet Evol 2008, 8:815-819.
- [4]Ahmed KS, Khan AA, Ahmed I, Tiwari SK, Habeeb A, Ahi JD, Abid Z, Ahmed N, Habibullah CM: Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med J 2007, 48:543-549.
- [5]Kumagai T, Malaty HM, Graham DY, Hosogaya S, Misawa K, Furihata K, Ota H, Sei C, Tanaka E, Akamatsu T, et al.: Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis 1998, 178:717-721.
- [6]Goodman KJ, Correa P, Tengana Aux HJ, Ramirez H, DeLany JP, Guerrero Pepinosa O, Lopez Quinones M, Collazos Parra T: Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol 1996, 144:290-299.
- [7]Ernst PB, Gold BD: The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000, 54:615-640.
- [8]Chen Y, Blaser MJ: Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007, 167:821-827.
- [9]Chen Y, Blaser MJ: Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008, 198:553-560.
- [10]Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A: Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011, 121:3088-3093.
- [11]Higgins PD, Johnson LA, Luther J, Zhang M, Sauder KL, Blanco LP, Kao JY: Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: Mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis 2011, 17:1398-1408.
- [12]Cohen D, Shoham O, Orr N, Muhsen K: An inverse and independent association between Helicobacter pylori infection and the ncidence of shigellosis and other diarrheal diseases. Clin Infect Dis 2012, 54:e35-42.
- [13]Dubois A, Fiala N, Heman-Ackah LM, Drazek ES, Tarnawski A, Fishbein WN, Perez-Perez GI, Blaser MJ: Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology 1994, 106:1405-1417.
- [14]Drazek ES, Dubois A, Holmes RK: Characterization and presumptive identification of Helicobacter pylori isolates from rhesus monkeys. J Clin Microbiol 1994, 32:1799-1804.
- [15]Allos BM: Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis 2001, 32:1201-1206.
- [16]Dingle KE, Van Den Braak N, Colles FM, Price LJ, Woodward DL, Rodgers FG, Endtz HP, Van Belkum A, Maiden MC: Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barre and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type. J Clin Microbiol 2001, 39:3346-3349.
- [17]Yuki N, Tagawa Y, Irie F, Hirabayashi Y, Handa S: Close association of Guillain-Barre syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha. J Neuroimmunol 1997, 74:30-34.
- [18]Moran AP, Prendergast MM: Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barre syndrome. J Infect Dis 1998, 178:1549-1551.
- [19]Andrade MC, Gabeira SC, Abreu-Lopes D, Esteves WT, Vilardo Mde C, Thome JD, Cabello PH, Lauria-Filgueiras AL: Circulation of Campylobacter spp. in rhesus monkeys (Macaca mulatta) held in captivity: a longitudinal study. Mem Inst Oswaldo Cruz 2007, 102:53-57.
- [20]Solnick JV, Chang K, Canfield DR, Parsonnet J: Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques. J Clin Microbiol 2003, 41:5511-5516.
- [21]Boonjakuakul JK, Canfield DR, Solnick JV: Comparison of Helicobacter pylori virulence gene expression in vitro and in the Rhesus macaque. Infect Immun 2005, 73:4895-4904.
- [22]Mattapallil JJ, Dandekar S, Canfield DR, Solnick JV: A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. Gastroenterology 2000, 118:307-315.
- [23]Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M: Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci U S A 2004, 101:2106-2111.
- [24]Styer CM, Hansen LM, Cooke CL, Gundersen AM, Choi SS, Berg DE, Benghezal M, Marshall BJ, Peek RM Jr, Boren T, Solnick JV: Expression of the BabA adhesin during experimental infection with Helicobacter pylori. Infect Immun 2010, 78:1593-1600.
- [25]Dabiri H, Maleknejad P, Yamaoka Y, Feizabadi MM, Jafari F, Rezadehbashi M, Nakhjavani FA, Mirsalehian A, Zali MR: Distribution of Helicobacter pyloricagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran. J Gastroenterol Hepatol 2009, 24:1380-1386.
- [26]Contreras M, Pujol FH, Perez-Perez GI, Marini E, Michelangeli FA, Ponce L, Dominguez-Bello MG: Helicobacter pylori seroprevalence in Amerindians from isolated locations. Am J Trop Med Hyg 2008, 78:574-576.
- [27]Torres J, Camorlinga-Ponce M, Perez-Perez G, Munoz L, Munoz O: Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection. Clin Diagn Lab Immunol 2002, 9:97-100.
- [28]Perez-Perez GI, Cohn DL, Guerrant RL, Patton CM, Reller LB, Blaser MJ: Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. J Infect Dis 1989, 160:460-468.
- [29]Blaser MJ, Black RE, Duncan DJ, Amer J: Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. J Clin Microbiol 1985, 21:164-167.
- [30]Blaser MJ, Taylor DN, Echeverria P: Immune response to Campylobacter jejuni in a rural community in Thailand. J Infect Dis 1986, 153:249-254.
- [31]Timmins RJ, Richardson M, Chhangani A, Yongcheng L: Macaca mulatta. IUCN 2012. IUCN Red List of Threatened Species. Version 2012.1 2008. [ www.iucnredlist.org webcite]. Downloaded on 20 August 2012
- [32]Shedlock DJ, Silvestri G, Weiner DB: Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Nat Rev Immunol 2009, 9:717-728.
- [33]Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, et al.: Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med 2005, 11:740-747.
- [34]Sparman M, Dighe V, Sritanaudomchai H, Ma H, Ramsey C, Pedersen D, Clepper L, Nighot P, Wolf D, Hennebold J, Mitalipov S: Epigenetic reprogramming by somatic cell nuclear transfer in primates. Stem Cells 2009, 27:1255-1264.
- [35]Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM: Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 2007, 450:497-502.
- [36]Taylor DN, Echeverria P, Pitarangsi C, Seriwatana J, Bodhidatta L, Blaser MJ: Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand. J Clin Microbiol 1988, 26:863-868.
- [37]Perez-Perez GI, Blaser MJ: Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987, 55:1256-1263.
- [38]Ng EK, Thompson SA, Perez-Perez GI, Kansau I, van der Ende A, Labigne A, Sung JJ, Chung SC, Blaser MJ: Helicobacter pylori heat shock protein A: serologic responses and genetic diversity. Clin Diagn Lab Immunol 1999, 6:377-382.
- [39]Gootz TD, Perez-Perez GI, Clancy J, Martin BA, Tait-Kamradt A, Blaser MJ: Immunological and molecular characterization of Helicobacter felis urease. Infect Immun 1994, 62:793-798.
- [40]Suerbaum S, Josenhans C, Sterzenbach T, Drescher B, Brandt P, Bell M, Droge M, Fartmann B, Fischer HP, Ge Z, et al.: The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A 2003, 100:7901-7906.
- [41]Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ: Campylobacter pylori antibodies in humans. Ann Intern Med 1988, 109:11-17.
- [42]Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, Echeverria PD, Blaser MJ: Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990, 161:1237-1241.
- [43]Faulde M, Putzker M, Mertes T, Sobe D: Evaluation of an immunofluorescence assay for specific detection of immunoglobulin G antibodies directed against Helicobacter pylori, and antigenic cross-reactivity between H. pylori and Campylobacter jejuni. J Clin Microbiol 1991, 29:323-327.
- [44]Karvar S, Karch H, Frosch M, Burghardt W, Gross U: Use of serum-specific immunoglobulins A and G for detection of Helicobacter pylori infection in patients with chronic gastritis by immunoblot analysis. J Clin Microbiol 1997, 35:3058-3061.
- [45]Vorobjova T, Nilsson I, Kull K, Maaroos HI, Covacci A, Wadstrom T, Uibo R: CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia. Eur J Gastroenterol Hepatol 1998, 10:41-46.
- [46]Solnick JV, Fong J, Hansen LM, Chang K, Canfield DR, Parsonnet J: Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral-oral transmission. J Clin Microbiol 2006, 44:3799-3803.
- [47]Dubois A, Berg DE, Incecik ET, Fiala N, Heman-Ackah LM, Perez-Perez GI, Blaser MJ: Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect Immun 1996, 64:2885-2891.
- [48]Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995, 55:2111-2115.
- [49]McCoy EC, Doyle D, Burda K, Corbeil LB, Winter AJ: Superficial antigens of Campylobacter (Vibrio) fetus: characterization of antiphagocytic component. Infect Immun 1975, 11:517-525.
- [50]Blaser MJ, Duncan DJ: Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun 1984, 44:292-298.